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Aims: We tested the hypothesis that immunoglobulin ameliorated experimental 
autoimmune myocarditis (EAM) in mice attributing to the suppression of reactive 
oxygen species (ROS)-mediated myocardial injury. Methods: We intraperitoneally 
administered intact type of human immunoglobulin (Ig) or F(ab)2 fragments of human 
immunoglobulin, 1g/kg/day daily for 3 weeks, to male BALB/c mice with heart failure 
due to EAM. Results: The results showed that intact type of Ig, but not F(ab)2 type, 
reduced the severity of myocarditis by comparing the heart weight/body weight  and 
lung weight/body weight ratios, pericardial effusion score, macroscopic and 
microscopic scores. Tissue superoxide production was marked in untreated mice with 
EAM, which was suppressed by the treatment of immunoglobulins. The cytotoxic 
activities of lymphocytes in mice with EAM treated with Ig were reduced compared 
with untreated controls. The shift from Th1 toward Th2 cytokine balance was 
demonstrated by the treatment of immunoglobulins both in vitro and in vivo. 
Conclusion: ROS may be involved in the development of myocarditis. Intact Ig 
ameliorates myocardial damage in mice with myocarditis associated with  
suppression of ROS and cytotoxic activity of lymphocytes. suppressive effects for 
cytotoxic myocardial injury. 
Keywords: myocarditis; reactive oxygen species; immune system; immunoglobulins 
 




 In humans, acute myocarditis is a potentially lethal disease, and frequently 
precedes the development of dilated cardiomyopathy (DCM). Two mechanisms to 
explain how myocarditis develops into DCM have been proposed; one is a persistent 
viral infection, and the other is a progressive autoimmune myocardial injury [1]. The 
autoimmune giant cell myocarditis in rats mimics human fulminant myocarditis in the 
acute phase [2]. 
 Recent reports indicated that immunoglobulin treatment suppressed the severity 
of acute myocarditis in clinical studies and experimental animals [3-5]. Moreover, we 
found that immunoglobulin therapy exhibited an anti-inflammatory action via 
inhibitory Fc receptor (Fc receptor II B) associated with the suppression of dendritic 
cells in an experimental autoimmune myocarditis (EAM) model [4,5]. However, the 
effects of immunoglobulin upon autoimmune heart failure are still unknown. 
 Recent studies have reported the significant participation of oxidative 
myocardial injury in the development of heart failure [6-8]. The purpose of the present 
study was to examine the effects of immunoglobulins on an EAM model, focusing on 
the inhibitory effects on oxidative myocardial injury. 
Materials and Methods 
Immunization  
 Autoimmune heart failure with EAM was induced by immunization with porcine 
cardiac myosin in 6-week-old male BALB/c mice as previously described [4-6]. 
Porcine cardiac myosin (Sigma) was injected subcutaneously in the foot pads with 0.1 
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ml of myosin (10 mg/ml) mixed with an equal volume of Freund's complete adjuvant 
(FCA) supplemented with Mycobacterium tuberculosis H37Ra (Difco) on days 1 and 8. 
Control mice were immunized with FCA alone. 
Medication 
 Mice with EAM were divided into three groups; they were intraperitoneally 
treated with phosphate buffered saline (PBS) (n=15), intact immunoglobulin (Ig) 
(n=12) (Venoglobulin-IH, Welfide Corporation, Japan, a polyethylene glycol treated 
human immunoglobulin,1g/kg/day), and F(ab)2 fragments (n=12) (Gamma-Venin, 
Aventis Corp,1g/kg/day) daily for 3 weeks. The dose was chosen because of the 
previous studies [4,5]. In addition, immunoglobulin antigenicity between different 
species (human and mouse) did not appear to be a problem, as described before [4,5]. 
In parallel with this protocol, additional control groups were age-matched 
unimmunized mice treated for 3 weeks with PBS (n=4), Ig (n=4), and F(ab)2 
fragments (n=4). All the mice were sacrificed at the end of the experiment, and the sera 
were processed for cytokine assay. The organs were weighed, and the ratio of organ 
weight-to-body weight was calculated. The investigation conforms with the Guide for 
the Care and Use of Laboratory Animals published by the US National Institutes of 
Health (NIH Publication No.85-23, revised 1985). The protocol was approved by the 
Institutional Animal Research Committee of Kyoto University, and the details of 
procedures were approved by the Ethics Committee. 
Histopathology 
 At sacrifice, macroscopic findings were graded on a scale of 0 to +4. 
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Microscopic findings for, myocardial necrosis, and cellular infiltration were graded on 
a scale of 0 to +4, as previously described [4,5,9]. After macroscopic examination, a 
part of the ventricles was embedded in optical cutting temperature (OCT) compound 
for immunohistochemistry; remnant tissues were processed for other studies. 
Immunohistochemical study 
 We used an immunoperoxidase technique to perform immunohistochemistry for
 
interleukin-1 (IL-1) staining and cell surface markers, as previously described 
[4,5,9]. In brief, anti-macrophage (anti-M, M3/84, 1:400, PharMingen), anti-CD4 
(GK1.5, 1:50, PharMingen), and anti-CD8 (53-6.7, 1:50, PharMingen) antibodies were 
applied to acetone-fixed cryosections. After being washed, the sections were then 
exposed to second antibodies (horseradish peroxidase-conjugated antibodies), and the 
antibody was visualized with diaminobenzidine. Sections were counterstained. The 
positive-staining cells of heart tissue were counted blindly by two observers in six 
fields at  400 magnification (within a 1-mm2 grid). The total positive-staining cells of 
the six fields were recorded as the number of infiltrating cells in the lesions, and the 
percentages of positive cells were calculated, as previously described [4,5,9]. 
Western Blotting  
 The myocardial lysates underwent sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) and were sequentially transferred to a membrane 
(Millipore) that was incubated with an anti-IL-1β(Secrotec) antibody, then with a 
peroxidase-linked secondary antibody (Amersham). Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was used as an internal control. Chemiluminescence was 
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detected and semiquantitatively analized using the NIH Image system[9]. 
In situ detection of superoxide production 
 To evaluate in situ superoxide production from hearts, unfixed frozen cross 
sections of the specimens were stained with dihydroethidium (DHE; Molecular Probe, 
OR) according to the previously validated method [9-11]. In the presence of 
superoxide, DHE is converted to the fluorescent molecule ethidium, which can then 
label nuclei by intercalating with DNA. Briefly, the unfixed frozen tissues were cut 
into 10-m thick sections, and incubated with 10 M DHE at 37C for 30 min in a 
light-protected humidified chamber. The images were obtained with a laser scanning 
confocal microscope. Superoxide production was demonstrated by red fluorescence 
labeling. 
 For quantification of ethidium fluorescence from hearts, fluorescence (intensity 
 area) was measured using the high-power image monitor. 
Electron spin resonance spectroscopy 
 The portions of excised heart were homogenized in cold PBS (0.1g heart/ml), 
and were then added to 0.05ml of 9.0ml of 5.5-dimethyl-1-pyrroline-1-oxide (DMPO) 
(Labotec). The generation of hydroxyl radicals ( OH) was observed as DMPO-OH 
adduct on a JEL-FR30 spectrometer, as described previously [13,14]. Quantification of 
the DMPO signal intensity was performed by comparing the observed signal to a 
standard Mn
2+
 marker; the hydroxyl radical signal relative to the internal standard of 
manganese ion was calculated. 




 To culture popliteal lymph node (LN) cells, LN cells were harvested from mice 
at sacrifice, and single-cell suspensions were obtained by passing through a stainless 
steel mesh screen. Cells were suspended in RPMI-1640 supplemented with fetal calf 
serum (FCS), 1% sodium pyruvate, 1% nonessential amino acids, 5× 10-5 M 
2-mercaptoethanol and penicillin-streptomycin mixture. 
Cytotoxicity assays 
 LN cells from mice treated with or without immunoglobulin were used as 
effector cells. F-2 cells (murine endothelial cells) plated in 96-micro-well plates (2×
10
4 
/ well) were labeled with sodium chromate at 1ci/well (51Cr, Amersham 
International) for 1 hour. After labeled target cells had been washed with PBS three 
times, LN cells were incubated at an effector-target (E/T) ratio of 50: 1 and 100 : 1 for 
4 hours. The supernatant was collected and the radioactivity of 
51
Cr released into the 
supernatant was measured by a gamma counter. The percentage of cytotoxicity was 
calculated using the formula 
 % cytotoxicity = ( E – S ) / ( M – S )×100 
where E is the counts per minute (cpm) released in the presence of effector cells, S is 
the spontaneous cpm released from target cells incubated in the medium, and M is the 
maximal cpm released from target cells incubated with 2% Triton X-100 [15,16]. 
Cytokine assays 
 The serum levels of cytokines in mice with and without EAM were determined 
in vivo by enzyme-linked immunosorbent assay (ELISA). 
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 In the in vitro study, U937 cells (macrophage-like cells bearing Fc receptors [4]) 
were stimulated with 10g/ml lipopolysaccharide (LPS). Ig or F(ab)2 fragments 
(0.6mg/ml) was added to the medium 30 min before LPS stimulation. Forty-eight 
hours later, cytokines in the medium was assayed by ELISA using commercially 
available kits (R&D System). 
Statistics 
 All values were expressed as meansstandard deviation (SD). One way analysis 
of variance (ANOVA), following by Fisher protected least significant difference test, 
was performed. A value of p<0.05 was considered statistically significant. 
Results 
Histopathology, organ weights in mice with EAM (Table 1) 
 There was no death during the study period in all the groups. 
 At sacrifice, the hearts showed severe and diffuse discolored myocarditis in mice 
immunized with cardiac myosin. Extensive injuries to myocytes with inflammatory 
changes and multinucleated giant cells associated with IL-1 e  xpression were 
observed (Figures 1, 2, 3). Treatment with Ig, but not with F(ab)2 fragments, reduced 
the severity of the disease (Table 1), as assessed by measuring organ weight/body 





 T cells recruited into the lesions were significantly reduced by the treatment 
of Ig and F(ab)2 fragments (Table 1). Myocardial IL-1β expression (17kDa), 
determined by immunohistochemistry and Western blotting, was upregulated in mice 
with EAM, and was suppressed by the treatment with Ig, but not with F(ab) fragments 
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(Figures 2, 3). 
Reactive oxygen species (Table 1) 
 There was no significant difference in staining intensity with DHE among 3 
unimmunized groups (data not shown). However, there was an increase in DHE 
staining in cardiac sections from untreated group. Namely, the brightness of 
DHE-stained hearts from untreated mice with EAM was stronger than that from 
immunoglobulins-treated mice with EAM (Table 1, Figure 2). 
Electron spin resonance spectrometric analysis (Table 2) 
 The formation of hydroxyl radical was detected in the myocarditic heart 
homogenates and was decreased in the Ig-
 
and F(ab)2 fragments-treated myocarditic 
heart homogenates compared with the untreated ones. Thus, the hydroxyl radical 
signals relative to the internal standard of manganese ion in the Ig- and F(ab)2 
fragments-treated hearts were lower compared with those in the untreated ones. 
Cytotoxic activity of lymphocytes (Table 2) 
 At E/T ratios of 50:1 and 100:1, the cytotoxic activities of lymphocytes from 
mice with EAM treated with Ig, but not with F(ab)2 fragments, were significantly 
suppressed compared with those from mice with EAM treated with PBS. 
Cytokine production (Tables 3 and 4) 
 Serum cytokines were elevated in mice with EAM. However, there was a 
decrease of cytokine level associated with a tendency of the shift from Th1 toward Th2 
balance in mice with EAM treated with Ig and F(ab)2 fragments (Table 3).  
 Cytokine production was markedly increased by LPS stimulation. Both the 
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immunoglobulin preparations suppressed LPS-induced increased cytokine production 
on U937 cells in a dose-dependent manner. However, Ig had more potent cytokine 
suppressive effects associated with the tendency favoring Th2 response than F(ab)2 
fragments (Table 4). 
Discussion 
 The present findings clearly demonstrated that Ig, but not F(ab)2 fragments, 
sufficiently suppressed the development of EAM, and that the cardioprotection may be 
due to the suppression of both the production of ROS and cytotoxic activity of 
lymphocytes against the heart via Fc portion of the immunoglobulin. The analysis of 
behavior of cytokines showed that immunoglobulin preparations induced 
anti-inflammatory effects, and that although treatment with F(ab')2 caused the in vitro 
anti-inflammatory effects to some extent, Ig induced a clear shift from Th1 toward Th2 
cytokine balance. 
 Several studies have described the participation of oxidative stress in the 
pathogenesis of heart failure [6-8,17,18]. Recent reports indicated that myocardial 
injury was produced by reactive oxygen species (ROS), and that lipid peroxidation was 
caused by ROS, resulting in cell membrane damage in heart failure [19-21]. Also, 
recent studies have definitely established the key role of the free radicals in the 
pathogenesis of heart failure by demonstrating that agents that inhibit the generation of 
free radical confer cardiovascular benefit. 





 T cells, and IL-1-positive inflammatory cells were markedly 
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reduced by immunoglobulins treatment. Decreased myocardial IL-1βexpression by Ig 
treatment was confirmed by Western blotting. Accordingly, it may be that the 
beneficial effects of immunoglobulins in EAM may be partly due to the suppression of 
inflammatory events in the myocardium. The molecular mechanisms of the agents in 
the suppression of inflammatory cytokines are not fully understood. However, the 
inhibition of signal transduction pathways, such as immunoreceptor tyrosine-based 
inhibitory motif via Fc receptor, which is particularly important in the regulation of 
cytokines by Fc portion of immunoglobulin, has been postulated [22-25]. 
 Next, Ig and F(ab)2 fragments scavenged the generation of hydroxyl radicals in 
heart homogenates ex vivo. It was demonstrated in the electron spin resonance 
spectroscopy study that immunoglobulins treatment protected against cellular protein 
oxidative damage in vivo. It was already demonstrated that free radicals, especially 
hydroxyl radicals, play an important role in the development of heart failure in this 
animal model [13,14]. Also, in the current study in DHE staining, superoxide 
production was markedly suppressed in Ig-treated group and moderately suppressed in 
F(ab)2 fragments-treated group. Although the reason why Fab portion has the free 
radical scavenging action to some extent is unclear, the Fc portion of  
immunoglobulin may act for radical scavengers, resulting in less severe myocardial 
damage. 
 Another important role of immunoglobulin is an immunomodulation. Although 
whether immunoglobulin directly affects the host immune status or not is unknown, it 
was demonstrated in this study that the overall effects of the drug could induce the 
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suppression of EAM associated with the reduction of cytotoxic activity; i.e., Ig 
suppressed the cytotoxic myocardial injury in mice with EAM. Indeed, the cytotoxic 
activities of lymphocytes against F-2 cells in mice with EAM treated with 
immunoglobulins were reduced compared with untreated controls.  
 Immune dysfunction in autoimmune diseases is known to be caused by an 
imbalance between Th1 and Th2. Th1 cytokines play critical roles in the differentiation 
of cardiac myosin-specific Th1 cells and the pathogenesis of EAM [2,4,5]. Although 
the precise mechanisms of cytokine shift from Th1 to Th2 by the drug is unknown, 
immunoglobulin preparations, especially Ig, induced the potent Th1 
cytokine-suppressive effect, resulting in the favoring Th2 cytokine response both in 
vitro and in vivo. Indeed, recent reports have indicated that treatment with Ig induced 
cytokine shift from Th1 to Th2 in patients with recurrent spontaneous abortion [26], and 
that pioglitazone, a peroxisome proliferator-activated receptor  activator and 
clarithromycin, a major macrobide antibiotic, ameliorate EAM associated with the 
modulation of Th1 / Th2 cytokine balance [27-29]. Accordingly, the cytokine shift from 
Th1 to Th2 may be in part due to the results associated with the amelioration of the 
condition[30]. 
 Oxidative stress and free radicals are known to impair normal cardiac function. 
Up to now there is increasing evidence for the generation of ROS reactive to the 
systemic and local inflammatory reactions in various diseases and for the significant 
role of free radicals upon the antigen presentating system [31,32]; inflammation itself 
and ROS may affect the function of antigen-presentating system. Recently, the 
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activating Fc receptor-coupled factor, Mincle, has been identified [33]. In addition, 
various tissues may generate ROS upon the exposure to Fc receptors-antigen 
complexes [31-33]. Accumulating evidence suggests the enhancement or modulation 
of antigen-presentating activity by ROS with and without Ig treatment [34-36]. The 
present study might have important implications for oxidative myocardial injury in 
relation to immune system.  
 In conclusion, Ig ameliorates EAM in mice. The cardioprotection of Ig is 
associated with the suppression of myocardial ROS production as well as the 
suppressive effects for cytotoxic myocardial injury concomitant with cytokine shift 
from Th1 toward Th2 balance. 
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Figure 1. Histopathology 
Diffuse myocardial necrosis and cellular infiltration with giant cells (arrowheads) were 
shown in the inflammatory lesions. Ig, but not F(ab)2 type, markedly suppressed the 
severity of EAM (Insets are transverse sections of myocardium). 
A=Normal mouse, B=Untreated mouse with EAM, C=Ig-treated mouse with EAM, D= 
F(ab)2 fragments-treated mouse with EAM. 
( 180) 
 
Figure 2. IL-1β staining, macrophage infiltration and DHE staining 
Intense IL-1β staining (brown areas) and positive macrophage infiltrations (arrows) 
were shown in the myocardium in untreated (B, inset  380) and F(ab)2 fragments- 
treated (D) mice with EAM, but not in Ig treated (C) mouse with EAM. In DHE 
staining, superoxide production was demonstrated by red fluorescence labeling. White 
arrows indicate the increased DHE stainings. Ig and F(ab)2 fragments suppressed the 
expressions of DHE compared with the untreated mouse with EAM. 
Each left panel=IL-1β staining, middle panel=macrophage staining, and right 
panel=DHE staining. 
A=Normal mouse, B=Untreated mouse with EAM, C=Ig-treated mouse with EAM, D= 
F(ab)2 fragments-treated mouse with EAM. 
( 180) 
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Figure 3. Myocardial IL-1βexpression 
(A) Western blot analysis of IL1β(17kDa).  
Representative Western blot analysis showed decreased expression of IL1β in 
Ig-treated mouse (lane 2) compared with control mouse (lane 1). 
GAPDH=glyceraldehyde-3-phosphate dehydrogenase.  
(B) Densitometric analysis of relative protein levels.  
The  expression of IL1β  in Ig-treated mice (lane 2), but not in F(ab)2 
fragments-treated mice (lane 3), was decreased compared with control mice(lane1). 
Values are derived from 5 animals and represent a ratio to GAPDH. 
lane1=untreated mouse with EAM, lane2= Ig-treated mouse with EAM, lane3= 




Table 1. Histological analysis 
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0 0  0  0 - - - - - - - - - - - - - - 







0 0  0  0 - - - - - - - - - - - - - - 







0 0  0  0 - - - - - - - - - - - - - - 
*P<0.05, **P<0.01 vs PBS.           (meanSD) 
BW=body weight, F(ab)2 = F(ab)2 fragments of immunoglobulin, FCA=Freund’s complete adjuvant, HW=heart weight, Ig=intact immunoglobulin,  
LiW=Liver weight, LuW=Lung weight, M=macrophage, PBS=phosphate-buffered saline. 
The positive-staining cells of heart itissue were counted blindly by two observers in six fields at x 400 magnification (within a 1-mm2 grid),and the 
total positive standing cells of the six fields were redorded as the number of infiltrating cells in the lesions, as previously described [4,5,9] 
There was no significant difference in staining with DHE among 3 control groups (FCA alone). 
Table 2. Cytotoxic activity and ESR spectrometric analysis 
 
Immunization Peritoneal Against F-2 cells (%) Hydroxyl Radical Signal Relative 
 Injection 50:1 100:1(E/T) to Internal Standard 
Myosin + FCA PBS 11.23.3 14.23.6 0.960.07 
  (n=5) (n=6) 
Myosin + FCA Ig 8.44.0* 9.23.3* 0.720.09** 
  (n=5) (n=6) 
Myosin + FCA F(ab)2 10.55.7 10.74.1 0.820.05* 
  (n=5) (n=6) 
*P<0.05 vs PBS.    (meanSD) 
E=effector, F(ab')2=F(ab')2 fragments of immunoglobulin, FCA=Freund’s complete adjuvant, Ig=intact immunoglobulin, 
PBS=phosphate-buffered saline, T=target. 
The cytotoxic activity in non-myocarditic groups (FCA alone) was very low（≤ 3.0%) at each E/T ratio. The formation of hydroxyl 




Table 3. Serum cytokine concentrations 
 
 Peritoneal  IL-1 IFN- IL-4 
Immunization Injection n (pg/ml) (pg/ml) (pg/ml) 
Myosin + FCA PBS 7 25252 9.42.6 <5.0 
Myosin + FCA Ig 7 11426 2.71.5 18.36.7 
Myosin + FCA F(ab)2 7 17645 5.73.1 10.45.3 
FCA alone PBS 4 <10.6 <0.1 <5.0 
FCA alone Ig 4 <10.6 <0.1 <5.0 
FCA alone F(ab)2 4 <10.6 <0.1 <5.0 
*P<0.05, **P<0.01 vs Control (Myosin + FCA). (meanSD) 
F(ab)2 = F(ab)2 fragments of immunoglobulin, FCA=Freund’s complete adjuvant, Ig=intact immunoglobulin, IFN-=interferon-, 
IL-4=interleukin 4, IL-1=interleukin-1, PBS=phosphate-buffered saline. 
 
Table 4. Effects of immunoglobulin preparations on cytokine production in vitro 
 
 Conditions    
LPS 
PBS Ig F(ab)2 
Il-1 IFN- IL-4 
(10g/ml) (pg/ml) (pg/ml) (pg/ml) 
 +   <10.6 <0.1 <5.0 
+ +   17522 52.27.5 <5.0 
  +  <10.6 <0.1 <5.0 
+  +  3517** 10.75.5** 23.55.0 
   + <10.6 <0.1 5.0 
+   + 5615** 40.06.2* 12.23.8 
Each value was derived from 4 to 5 independent trials. (meanSD) 
*P<0.05, ** P<0.01 vs the 2nd panel value [LPS (+), PBS (+), Ig (-), F(ab)2 (-)]. 
F(ab)2 = F(ab)2 fragments of immunoglobulin, FCA=Freund’s complete adjuvant, Ig=intact immunoglobulin, IFN-=interferon-, 
IL-4=interleukin 4, IL-1=interleukin-1, LPS=lipopoilysaccharide, PBS=phosphate-buffered saline. 
 
 
